Construction and Evaluation of Pancreatitis Animal Models: Acute Inflammation, Chronic Fibrosis, and Etiological Simulation Research
Construction and Evaluation of Pancreatitis Animal Models: Acute Inflammation, Chronic Fibrosis, and Etiological Simulation Research
Pancreatitis animal models are used to simulate acute acinar cell injury, abnormal pancreatic enzyme activation, inflammatory cascade responses, microcirculatory disturbance, and chronic fibrotic progression. Model selection should be based on the research focus, such as acute pancreatitis (AP), severe necrotizing pancreatitis, chronic pancreatitis (CP), or a specific etiology. Cerulein, sodium taurocholate, L-arginine, pancreatic duct ligation, alcohol combined with a high-fat diet, and genetic background models correspond to different pathological entry points and cannot simply replace one another.
Keywords: pancreatitis model; animal modeling; acute pancreatitis; chronic pancreatitis; cerulein; sodium taurocholate; L-arginine; pancreatic enzyme activation; pancreatic fibrosis
1 Experimental Positioning of Pancreatitis Models
1.1 Core Objectives of Model Establishment
(1) Acute acinar cell injury
Acute pancreatitis models focus on acinar cell edema, vacuolization, premature pancreatic enzyme activation, inflammatory cell infiltration, and increased serum amylase and lipase levels. The cerulein model is suitable for studies of mild to moderate edematous AP. The sodium taurocholate retrograde pancreaticobiliary duct injection model is more suitable for biliary and necrotizing AP research. The L-arginine model is commonly used to evaluate more severe acinar cell injury, oxidative stress, and systemic inflammatory responses.
(2) Chronic inflammation and fibrotic progression
Chronic pancreatitis models focus more on acinar atrophy, ductal reaction, pancreatic stellate cell activation, collagen deposition, and decreased exocrine function. Repeated cerulein stimulation, pancreatic duct ligation, and alcohol combined with a high-fat diet can all be used for CP research, but their emphases differ. The repeated cerulein model emphasizes recurrent inflammatory injury, the pancreatic duct ligation model emphasizes duct obstruction and fibrosis, and the alcohol combined with high-fat diet model is closer to metabolism- and lifestyle-related etiologies.
(3) Etiological and molecular mechanism simulation
Different models correspond to different etiological clues. Biliary AP research can use the sodium taurocholate model; hereditary pancreatitis mechanisms can use PRSS1 mutation- or SPINK1 deficiency-related models; alcoholic CP research is better suited to alcohol exposure combined with a high-fat diet or repeated stimulation models. If the research focus is NF-κB, NLRP3, TGF-β/Smad, autophagy, or oxidative stress, the model should be selected according to the disease stage in which the pathway is involved, rather than only according to modeling convenience.
1.2 Experimental Animals and Model Selection
Mice and rats are the most commonly used animals in pancreatitis research. Mice are suitable for mechanistic studies, genetically modified models, and multi-index molecular detection. Rats are suitable for surgical manipulation, pancreaticobiliary duct injection, tissue sampling, and serum biochemical testing. When selecting a model, disease type, lesion severity, observation window, mortality risk, operational stability, and compatibility with evaluation indicators should all be considered.
Table 1 Selection Logic of Pancreatitis Animal Models
Research Purpose | Recommended Model | Main Mechanism | Applicable Evaluation Indicators |
Mechanistic research on mild to moderate acute pancreatitis | Cerulein-induced model | CCK-like stimulation, acinar cell injury, inflammatory response | Amylase, lipase, pancreatic edema, MPO, TNF-α, IL-6 |
Biliary or necrotizing AP research | Sodium taurocholate retrograde pancreaticobiliary duct injection model | Bile acid toxicity, ductal hypertension, calcium overload, necrotizing inflammation | Histological necrosis score, IL-1β, NLRP3, MPO, mortality |
Severe AP and systemic inflammation research | L-arginine-induced model | Acinar cell toxic injury, oxidative stress, inflammatory factor release | Amylase, lipase, MDA, SOD, LDH, remote organ injury indicators |
Chronic inflammation and fibrosis research | Repeated cerulein stimulation model | Recurrent acinar injury, inflammation-repair cycle, fibrosis formation | α-SMA, Collagen I, TGF-β, Masson staining |
Obstructive CP research | Pancreatic duct ligation model | Pancreatic juice retention, acinar atrophy, ductal reaction, and fibrosis | Acinar atrophy, duct dilation, collagen deposition, pancreatic weight |
Alcoholic CP research | Alcohol combined with high-fat diet model | Alcohol metabolism, lipotoxicity, oxidative stress, and ER stress | ALDH, ALDH2, CHOP, MDA, inflammatory factors, fibrosis indicators |
Hereditary pancreatitis research | PRSS1, SPINK1, and other genetic background models | Imbalanced trypsin activation, autophagy abnormalities, chronic inflammation | Trypsinogen, TAP, Cathepsin B, p62, STAT3 |
1.3 Common Inducing Factors and Modeling Positioning
Modeling reagents and inducing factors should be placed at the front end of model selection to explain the etiological background and applicable research directions simulated by different models. Evaluation products should be placed in the latter part of the article to explain how injury, inflammation, pancreatic enzyme activation, and histopathological changes are detected after model establishment.
Table 2 Common Inducing Factors and Modeling Positioning in Pancreatitis Animal Models
Modeling Category | Inducing Factor/Modeling Material | CAS No. | Main Simulated Type | Modeling Positioning |
Chemically induced AP model | Cerulein/Ceruletide | Mild to moderate acute pancreatitis | Induces acinar cell injury, abnormal pancreatic enzyme activation, and inflammatory responses through CCK-like stimulation; suitable for AP early mechanisms and drug protective effect research | |
Biliary AP model | Sodium Taurocholate | Biliary/necrotizing acute pancreatitis | Simulates bile reflux, ductal hypertension, and bile acid toxic injury through retrograde pancreaticobiliary duct injection; suitable for severe AP and necrotizing inflammation research | |
Severe AP model | L-Arginine | Severe acute pancreatitis | Induces acinar cell metabolic stress, oxidative stress, and inflammatory responses; suitable for pancreatic necrosis and remote organ injury research | |
Nutritional-metabolic AP model | Ethionine | Nutrition/metabolism-related acute pancreatitis | Often used together with a choline-deficient diet to simulate severe nutrition/metabolism disorder-related pancreatic injury | |
Alcoholic CP model | Ethanol | 64-17-5 | Alcoholic chronic pancreatitis | Used in alcohol exposure or alcohol combined with high-fat diet models; suitable for oxidative stress, lipotoxicity, and chronic inflammation research |
Chronic inflammation-fibrosis model | Repeated cerulein stimulation | Chronic pancreatitis/fibrosis | Induces acinar atrophy, stellate cell activation, and collagen deposition through recurrent acinar cell injury and inflammation-repair cycles | |
Obstructive CP model | Pancreatic duct ligation | - | Obstructive chronic pancreatitis | Simulates ductal hypertension, acinar atrophy, and fibrosis formation through impaired pancreatic juice drainage; suitable for ductal reaction and tissue remodeling research |
Hereditary pancreatitis model | PRSS1 mutation model | - | Hereditary pancreatitis | Used to study abnormal trypsinogen activation, chronic inflammation, and genetic susceptibility |
Genetic susceptibility model | SPINK1 deficiency/mutation model | - | Genetically susceptible pancreatitis | Used to study decreased trypsin inhibition capacity, autophagy abnormalities, and acinar cell injury |
2 Chemically Induced Models of Acute Pancreatitis
2.1 Cerulein-Induced Model
(1) Model mechanism
Cerulein is a cholecystokinin analog that can overstimulate acinar cell secretory responses, causing abnormal zymogen granule trafficking, disrupted intracellular calcium signaling, and premature trypsinogen activation. This model usually shows pancreatic edema, acinar cell vacuolization, inflammatory cell infiltration, and increased serum amylase and lipase levels. It is suitable for studying early inflammatory amplification, acinar cell injury, and drug protective effects in AP.
(2) Experimental interpretation
The advantages of the cerulein model are good reproducibility, relatively stable operation, and low mortality. Its limitation is that the lesions are mostly edematous and mild to moderate, while necrosis and multi-organ injury are less prominent than in sodium taurocholate or L-arginine models. If used for drug screening, serum enzymology, pancreatic wet/dry weight ratio, HE score, MPO activity, and inflammatory factors should be evaluated together, rather than judging model severity only by increased amylase.
2.2 Sodium Taurocholate Retrograde Pancreaticobiliary Duct Injection Model
(1) Model mechanism
The sodium taurocholate model simulates bile reflux, pancreaticobiliary duct hypertension, and bile acid toxic injury through retrograde pancreaticobiliary duct injection. Bile acids can directly damage acinar cells and ductal epithelium, causing calcium overload, mitochondrial dysfunction, abnormal pancreatic enzyme activation, and tissue necrosis. This model is commonly used in biliary AP, severe AP, and necrotizing pancreatitis research.
(2) Experimental interpretation
This model produces severe lesions and can form marked edema, hemorrhage, necrosis, and systemic inflammatory responses, but it is highly sensitive to surgical technique, injection location, injection speed, and animal condition. Studies should focus on tissue necrosis extent, inflammatory infiltration, NLRP3 inflammasome, IL-1β, MPO activity, and remote organ injury. If the experimental goal is mild to moderate AP or early drug screening, this model may be too strong and should be used cautiously.
2.3 L-Arginine-Induced Model
(1) Model mechanism
High-load L-arginine can induce acinar cell metabolic stress, mitochondrial injury, and increased oxidative stress, thereby causing pancreatic parenchymal injury and inflammatory responses. This model is commonly used in studies of severe AP, pancreatic necrosis, systemic inflammatory response, and remote organ injury, and is especially suitable for observing the relationship between pancreatic injury and responses in the liver, lung, kidney, and other organs.
(2) Experimental interpretation
The lesion severity and animal tolerance of the L-arginine model are strongly affected by administration conditions, animal strain, body weight, and nutritional status. Evaluation should simultaneously detect pancreatic histology, serum enzymology, LDH, oxidative stress indicators, and multi-organ injury indicators. If the research focus is biliary etiology or ductal hypertension mechanisms, this model has insufficient etiological correspondence.
2.4 Choline-Deficient Ethionine-Supplemented Diet Model
The choline-deficient ethionine-supplemented diet model can induce severe acute pancreatic injury and systemic inflammatory responses and is commonly used in nutrition/metabolism disorder-related AP research. This model may show pancreatic necrosis, elevated inflammatory factors, and high mortality risk, but it is sensitive to animal sex, age, and feeding status. Because the model is relatively severe, ethical endpoints and observation windows should be clearly defined in the experimental design.
Table 3 Comparison of Acute Pancreatitis Models
Model Type | Common Inducing Factor | Main Pathological Features | Advantages | Limitations |
Cerulein-induced model | Cerulein | Acinar cell edema, vacuolization, inflammatory infiltration | Good reproducibility; suitable for early mechanisms and drug screening | Mostly mild to moderate AP, with insufficient necrotic features |
Sodium taurocholate model | Sodium taurocholate retrograde pancreaticobiliary duct injection | Hemorrhage, necrosis, severe inflammatory response | Close to biliary and necrotizing AP | Technically difficult, with relatively large within-group variation |
L-arginine model | L-Arginine | Acinar necrosis, oxidative stress, systemic inflammation | Suitable for severe AP and remote organ injury research | Lesion severity is strongly affected by animal condition |
Choline-deficient ethionine-supplemented diet model | Choline-deficient diet combined with ethionine | Severe pancreatitis and systemic inflammation | Suitable for nutrition/metabolism-related AP research | High mortality risk and strict condition control requirements |
3 Chronic Pancreatitis Models
3.1 Repeated Cerulein Stimulation Model
(1) Model mechanism
Repeated cerulein stimulation causes acinar cells to repeatedly undergo injury, inflammatory infiltration, and repair. Long-term stimulation leads to acinar atrophy, ductal reaction, stellate cell activation, and collagen deposition. This model is commonly used to study early inflammation-to-fibrosis transition in CP and is also suitable for evaluating anti-inflammatory and anti-fibrotic candidate drugs.
(2) Experimental interpretation
The key to the repeated cerulein model is not the severity of a single acute injury, but the accumulation of fibrosis after repeated injury. Masson staining, Sirius Red staining, α-SMA, Collagen I/III, TGF-β, and Smad3 should serve as core evaluation indicators. If only amylase and lipase are detected, it is difficult to demonstrate whether CP modeling is sufficient.
3.2 Pancreatic Duct Ligation Model
(1) Model mechanism
Pancreatic duct ligation blocks pancreatic juice drainage, causing increased ductal pressure, acinar atrophy, inflammatory cell infiltration, and fibrosis formation. This model is suitable for simulating duct obstruction-related CP and pancreatic parenchymal structural remodeling, and is commonly used to study acinar-to-ductal metaplasia, stellate cell activation, and extracellular matrix deposition.
(2) Experimental interpretation
The evaluation focus of the pancreatic duct ligation model includes duct dilation, acinar atrophy, fibrosis extent, and changes in pancreatic tissue structure. This model requires high surgical consistency, and ligation site and postoperative observation time can significantly affect results. If used for drug intervention, the effects of drugs on inflammation, fibrosis, and tissue atrophy should be distinguished, rather than using pancreatic weight change as the only endpoint.
3.3 Alcohol Combined with High-Fat Diet Model
(1) Model mechanism
Alcohol exposure can increase ROS through acetaldehyde generation, CYP2E1 activation, and mitochondrial injury. A high-fat diet can enhance lipotoxicity, inflammatory responses, and endoplasmic reticulum stress. Their combination can promote acinar cell injury, stellate cell activation, and chronic fibrosis, making it more suitable for studying alcoholic or metabolism-related CP.
(2) Experimental interpretation
This model usually progresses slowly, and alcohol exposure alone may not reliably produce typical CP lesions. Experiments should focus on ALDH, ALDH2, CYP2E1, CHOP, GRP78, MDA, GSH, and fibrosis indicators. If the research goal is a clear fibrosis endpoint, it is often necessary to combine this model with repeated inflammatory stimulation or other injurious factors.
3.4 Genetic Background Models
PRSS1 mutation models can be used to simulate hereditary pancreatitis related to abnormal trypsinogen activation, while SPINK1 deficiency models can be used to study pancreatic enzyme imbalance caused by decreased trypsin inhibition capacity. Some models can also be combined with CFTR, CPA1, autophagy-related genes, or inflammatory pathway genes to study genetic susceptibility. The advantage of genetic background models is clear mechanism, while their limitation is a relatively single etiology and difficulty in fully covering human CP caused by the combined effects of alcohol, biliary factors, metabolism, genetics, and environmental factors.
Table 4 Comparison of Chronic Pancreatitis Models
Model Type | Modeling Characteristics | Main Mechanism | Applicable Research Direction | Key Control Points |
Repeated cerulein model | Repeated stimulation induces inflammation-repair cycles | Acinar injury, persistent inflammation, fibrosis formation | Early CP mechanisms and anti-fibrotic efficacy | Stimulation cycle, observation endpoint, histological scoring |
Pancreatic duct ligation model | Surgical blockage of pancreatic juice drainage | Ductal hypertension, acinar atrophy, fibrosis | Obstructive CP, ductal reaction, tissue remodeling | Ligation site, postoperative time, surgical consistency |
Alcohol combined with high-fat diet model | Long-term metabolic and dietary intervention | Oxidative stress, lipotoxicity, ER stress | Alcoholic CP and metabolism-related pancreatic injury | Diet composition, exposure cycle, animal tolerance |
PRSS1-related model | Expression of trypsinogen mutation | Abnormal pancreatic enzyme activation, chronic inflammation | Hereditary pancreatitis and inflammation-cancer transition | Genetic background, disease stage, phenotype stability |
SPINK1-related model | Reduced trypsin inhibition capacity | Pancreatic enzyme imbalance, autophagy abnormalities, acinar injury | Genetic susceptibility, autophagy, and pancreatic enzyme regulation | Genotype confirmation and tissue injury severity |
4 Mechanistic Evaluation of Pancreatitis Models
4.1 Pancreatic Enzyme Activation and Acinar Cell Injury
Premature trypsinogen activation is an important step in early AP injury. Cathepsin B can promote abnormal intracellular activation of trypsinogen, leading to acinar cell autodigestion, cell membrane injury, and initiation of inflammatory responses. Trypsin activity, TAP, trypsinogen, Cathepsin B, intracellular calcium signaling, and acinar cell vacuolization can serve as evaluation indicators for this step.
4.2 Inflammatory Cascade Response
After NF-κB pathway activation, the release of pro-inflammatory factors such as TNF-α, IL-1β, and IL-6 is promoted, further recruiting neutrophils and macrophages. In severe AP, the NLRP3 inflammasome, Caspase-1, and IL-1β maturation are closely associated with necrotizing inflammation and systemic inflammatory responses. MPO activity can be used to reflect the degree of neutrophil infiltration.
4.3 Oxidative Stress and Microcirculatory Disturbance
ROS accumulation, mitochondrial dysfunction, and reduced antioxidant capacity can aggravate acinar cell injury. Increased MDA and decreased SOD and GSH are commonly used to assess oxidative injury. In necrotizing AP, vascular endothelial injury, platelet activation, local ischemia, and microcirculatory disturbance should also be considered. When necessary, tissue perfusion, endothelial injury, and coagulation-related indicators should be detected together.
4.4 Chronic Fibrosis and Stellate Cell Activation
The core pathological changes of CP are acinar atrophy, ductal reaction, and fibrosis. After activation, pancreatic stellate cells express α-SMA and secrete Collagen I, Collagen III, and Fibronectin. The TGF-β/Smad3 pathway is an important regulatory axis in fibrosis formation. When evaluating CP models, histological staining and fibrosis-related molecular indicators should be used together to avoid judging chronic lesions only by inflammatory factors.
Table 5 Common Evaluation Indicators for Pancreatitis Models
Evaluation Level | Common Indicators | Application Value | Applicable Models |
Serum enzymology | Amylase, lipase | Determines AP modeling success and acinar injury severity | Cerulein, sodium taurocholate, L-arginine |
Gross injury | Pancreatic edema, hemorrhage, necrosis, wet/dry weight ratio | Determines lesion severity and tissue edema | AP models |
Histology | HE score, necrotic area, inflammatory infiltration, acinar atrophy | Evaluates injury type and pathological stage | AP and CP models |
Inflammatory response | TNF-α, IL-1β, IL-6, MPO | Determines inflammatory factor release and neutrophil infiltration | AP, severe AP, CP |
Inflammasome | NLRP3, Caspase-1, IL-1β, GSDMD | Evaluates necrotizing inflammation and pyroptosis-related mechanisms | Sodium taurocholate and severe AP models |
Oxidative stress | MDA, SOD, GSH, GSH-Px, ROS | Determines oxidative injury and antioxidant defense | AP and alcohol-related models |
Pancreatic enzyme activation | Trypsin activity, TAP, trypsinogen, Cathepsin B | Analyzes abnormal pancreatic enzyme activation and acinar autodigestion | Cerulein and genetic background models |
Cell injury | LDH, cell viability, cell death rate | Evaluates acinar cell injury and cytotoxicity in in vitro models | In vitro acinar cell models and AP models |
Autophagy | LC3-II, Beclin-1, p62/SQSTM1 | Evaluates autophagic flux and acinar cell stress | AP and SPINK1-related models |
Fibrosis | α-SMA, Collagen I/III, Fibronectin, hydroxyproline | Determines stellate cell activation and ECM deposition | CP models |
Fibrotic pathway | TGF-β, Smad2/3, p-Smad3 | Analyzes fibrotic signaling pathways | Pancreatic duct ligation, repeated cerulein, alcohol models |
Remote organ injury | Pulmonary edema, ALT, AST, Cr, BUN, inflammatory factors | Evaluates systemic injury in severe AP | Sodium taurocholate and L-arginine models |
5 Supplementary Applications of In Vitro and Ex Vivo Models
5.1 Acinar Cell Injury Models
AR42J cells and primary pancreatic acinar cells can be used to simulate acinar cell stress, pancreatic enzyme activation, abnormal calcium signaling, oxidative stress, and inflammatory factor release. Cell models are suitable for preliminary mechanistic screening, such as NF-κB, NLRP3, autophagy, mitochondrial injury, and candidate drug protective effects.
Cell models cannot fully simulate pancreatic tissue structure, ductal pressure, immune cell infiltration, and microcirculatory disturbance. Therefore, in vitro results should be used as mechanistic clues, while key conclusions still need validation by animal models and histological results.
5.2 Pancreatic Stellate Cell Models
Pancreatic stellate cells are suitable for studying CP fibrosis mechanisms. TGF-β stimulation, alcohol metabolites, or inflammatory factors can induce stellate cell activation, characterized by increased α-SMA, increased collagen secretion, and enhanced extracellular matrix deposition. This model is suitable for preliminary screening of anti-fibrotic drugs, but cannot independently represent the complete CP disease course.
5.3 Pancreatic Tissue Slices and Organoid Models
Ex vivo pancreatic tissue slices can preserve partial tissue structure and cell-cell interactions, making them suitable for observing short-term effects of drugs on acinar cells, ductal reactions, and inflammatory signaling. Pancreatic organoids are more suitable for studying ductal epithelium, regeneration and repair, and genetic background-related mechanisms, but have limited ability to simulate inflammatory infiltration and blood flow factors.
Table 6 Application Positioning of In Vivo and In Vitro Models in Pancreatitis Research
Model Level | Common System | Applicable Question | Main Limitation |
Animal models | Mice, rats, genetically engineered animals | Pancreatitis occurrence, inflammatory infiltration, fibrosis, drug efficacy evaluation | High cost, requiring ethical approval and model consistency control |
Acinar cell models | AR42J, primary acinar cells | Pancreatic enzyme activation, calcium signaling, autophagy, oxidative stress | Lack tissue structure, immune microenvironment, and blood flow factors |
Stellate cell models | Primary or passaged pancreatic stellate cells | Fibrosis, ECM deposition, TGF-β pathway | Cannot simulate acinar-ductal-immune cell interactions |
Pancreatic tissue slices | Ex vivo pancreatic tissue | Local tissue response and short-term drug effects | Limited survival time and difficulty simulating long-term progression |
Pancreatic organoids | Pancreatic ductal or acinar-related organoids | Epithelial repair, genetic mechanisms, drug screening | Insufficient simulation of inflammation and microcirculation |
6 Related Product and Material Selection
Table 7 Products Related to Pancreatic Injury and Serum Enzymology Evaluation
Product Category | Cat. No. | Product/Material Name | Grade & Purity | Application Positioning |
Amylase activity detection | α-Amylase (α-AL) Activity Assay Kit (DNS, Micro Method) | BioReagent | Used for amylase activity detection in acute pancreatitis models; suitable for enzymatic evaluation of serum or tissue samples | |
Amylase activity detection | α-Amylase (α-AMS) Activity Assay Kit (DNS, Colorimetric Method) | BioReagent | Used for α-amylase activity detection in AP models and can serve as one serum enzymology indicator | |
Amylase activity detection | Amylase (AMS) Activity Assay Kit (Iodine Solution, Micro Method) | BioReagent | Used for total amylase activity detection; suitable for small-volume samples and multi-group comparisons | |
Amylase activity detection | Amylase (AMS) Activity Assay Kit (Iodine Solution, Colorimetric Method) | BioReagent | Used for evaluating serum or tissue amylase activity in AP models | |
Animal sample amylase detection | Rat Amylase (AMS) ELISA Kit | BioReagent | Used for detecting amylase levels in rat acute pancreatitis models | |
Animal sample pancreatic amylase detection | Rat Amylase, Alpha 2A (PAMYα2) ELISA Kit | BioReagent | Used for detecting pancreas-derived amylase in rats; more suitable for pancreatic injury evaluation | |
Animal sample amylase detection | Mouse Alpha Amylase(α-AMS) ELISA Kit | BioReagent | Used for detecting α-amylase levels in mouse AP models | |
Animal sample pancreatic amylase detection | Mouse Amylase, Alpha 2A (PAMYα2) ELISA Kit | BioReagent | Used for detecting pancreas-derived amylase in mouse pancreatitis models | |
Lipase activity detection | Lipase (LPS) Activity Assay Kit (Copper soap, Micro Method) | BioReagent | Used for lipase activity detection in AP models and can be combined with amylase to evaluate pancreatic exocrine enzyme release | |
Animal sample pancreatic lipase detection | Mouse Lipase, Pancreatic (PL) ELISA Kit | BioReagent | Used for detecting pancreatic lipase levels in mouse pancreatitis models | |
Cell injury detection | Lactate Dehydrogenase (LDH) Cytotoxicity Assay Kit (DNPH, Micro Method) | BioReagent | Used for detecting cell injury and necrosis degree; suitable for in vitro mechanistic validation | |
LDH activity detection | Lactate Dehydrogenase (LDH) Activity Assay Kit (LD-L, Colorimetric Method) | BioReagent | Used for LDH activity evaluation in tissue or cell samples, reflecting the degree of cell injury | |
LDH activity detection | Lactate Dehydrogenase (LDH) Activity Assay Kit (LD-P, UV Colorimetric Method) | BioReagent | Used for LDH activity detection and can serve as a supplementary indicator of pancreatic cell injury | |
Cell injury detection | Lactate Dehydrogenase (LDH) Cytotoxicity Assay Kit (DNPH, Colorimetric Method) | BioReagent | Used for cytotoxicity detection in in vitro pancreatic cell injury models | |
Animal sample LDH detection | Rat Lactate Dehydrogenase (LDH) ELISA Kit | BioReagent | Used for evaluating tissue injury or systemic injury in rat AP models | |
Animal sample LDH detection | Mouse Lactate Dehydrogenase (LDH) ELISA Kit | BioReagent | Used for detecting LDH levels in mouse pancreatitis models | |
Animal sample LDH-A detection | Rat Lactate Dehydrogenase A (LDHA) ELISA Kit | BioReagent | Can be used for analysis related to cell injury and metabolic stress in rat models | |
Animal sample LDH-A detection | Mouse Lactate Dehydrogenase A (LDH-A) ELISA Kit | BioReagent | Can be used for evaluating tissue injury and glycolytic stress in mouse pancreatitis models |
Table 8 Products Related to Trypsin Activation and Cathepsin B Mechanism Evaluation
Product Category | Cat. No. | Product/Material Name | Grade & Purity | Application Positioning |
Trypsin activity detection | Trypsase Activity Assay Kit (TAME, Micro Method) | BioReagent | Used for evaluating trypsin activity; suitable for studying abnormal pancreatic enzyme activation in AP models | |
Trypsin activity detection | Trypsin Activity Assay Kit (TAME, Colorimetric Method) | BioReagent | Used for trypsin activity detection and can serve as an indicator of pancreatic autodigestion mechanisms | |
Trypsin detection | Human Trypsin ELISA Kit | BioReagent, for ELISA | Suitable for trypsin-related detection in human samples or human-derived in vitro models | |
TAP detection | Rat Trypsinogen Activation Peptide (TAP) ELISA Kit | BioReagent | Used for evaluating the degree of trypsinogen activation in rat AP models; suitable for early pancreatic enzyme activation research | |
TAP detection | Mouse Trypsinogen Activation Peptide (TAP) ELISA Kit | BioReagent | Used for TAP detection in mouse AP models, reflecting abnormal trypsinogen activation | |
Cathepsin B mechanism detection | Cathepsin B Mouse mAb | Carrier-free, ExactAb™, azide-free, validated, high performance, see COA | Used for Cathepsin B expression detection; suitable for research on abnormal trypsinogen activation mechanisms | |
Cathepsin B mechanism detection | Recombinant Cathepsin B Antibody | KD Validation | Used for Cathepsin B-related mechanistic validation and can be combined with WB, IHC, or IF experimental design | |
Cathepsin B protein | Recombinant Human Cathepsin B Protein | Animal-free, carrier-free, bioactive, ActiBioPure™, His tag, PBS Only, ≥95%(SDS-PAGE) | Can be used for Cathepsin B-related in vitro enzymology, antibody validation, or mechanism research | |
Cathepsin B protein | Recombinant Mouse Cathepsin B Protein | Animal-free, carrier-free, bioactive, ActiBioPure™, His tag, ≥95%(SDS-PAGE) | Can be used for mouse-derived mechanism research, methodological validation, or positive material setup |
Table 9 Supplementary Evaluation Products for Alcohol-Related Chronic Pancreatic Injury
Product Category | Cat. No. | Product/Material Name | Grade & Purity | Application Positioning |
Acetaldehyde metabolism detection | Acetaldehyde Dehydrogenase (ALDH) Activity Assay Kit (WST-8, Micro Method) | BioReagent | Used for evaluating acetaldehyde metabolism capacity in alcoholic chronic pancreatic injury models | |
Acetaldehyde metabolism detection | Acetaldehyde Dehydrogenase (ALDH) Activity Assay Kit (WST-8, Colorimetric Method) | BioReagent | Used for ALDH activity detection in alcohol exposure-related models | |
Acetaldehyde metabolism detection | Acetaldehyde Dehydrogenase (ALDH) Activity Assay Kit (UV Micro Method) | BioReagent | Used for research linking alcohol metabolism and oxidative stress | |
Animal sample ALDH2 detection | Rat Aldehyde Dehydrogenase, Mitochondrial (ALDH2) ELISA Kit | BioReagent | Used for detecting ALDH2 levels in rat alcoholic CP models | |
Animal sample ALDH detection | Mouse Acetaldehyde Dehydrogenase (ALDH) ELISA Kit | BioReagent | Used for evaluating ALDH levels in mouse alcohol exposure models | |
Animal sample ALDH2 detection | Mouse Aldehyde Dehydrogenase, Mitochondrial (ALDH2) ELISA Kit | BioReagent | Used for ALDH2-related detection in mouse alcoholic pancreatic injury models |
Table 10 Products Related to Pancreatic Histopathological Evaluation
Product Category | Cat. No. | Product/Material Name | Grade & Purity | Application Positioning |
Histological staining | Modified Hematoxylin-Eosin (HE) Staining Kit | BioReagent, for microscopy, for cell culture | Used for basic pathological evaluation of pancreatic necrosis, edema, inflammatory infiltration, and acinar structural destruction | |
Histological staining | Hematoxylin-Eosin (HE) High-Definition Consistent Staining Kit (High-Definition Stable Staining) | BioReagent, biological stain, for microscopy | Used for pancreatic tissue HE staining; suitable for pathological scoring and image presentation | |
Histological staining | Hematoxylin-Eosin (HE) Staining Kit (with Differentiating Solution) | BioReagent, biological stain, for microscopy | Used for routine HE staining of pancreatic tissue in AP/CP models | |
Histological staining | Hematoxylin-Eosin (HE) Staining Kit (with Differentiating Solution and Bluing Solution) | BioReagent, biological stain, for microscopy | Used for routine pathological observation of pancreatic tissue; suitable for determining model success and injury scoring |
7 Common Questions
7.1 How Should the Cerulein Model and Sodium Taurocholate Model Be Selected in Acute Pancreatitis Research?
The cerulein model is suitable for mild to moderate AP, acinar cell injury, and early inflammatory mechanism research. It has relatively good model stability and is suitable for preliminary drug screening. The sodium taurocholate model is more suitable for biliary AP, necrotizing AP, and severe inflammatory response research, but has higher operational difficulty and mortality risk. If the research goal is inflammatory pathways or preliminary screening of protective effects, the cerulein model is more appropriate. If the research focuses on necrosis, microcirculatory disturbance, or severe AP, the sodium taurocholate model should be selected.
7.2 Can Chronic Pancreatitis Models Be Evaluated Only by Serum Amylase and Lipase?
This is not recommended. Serum amylase and lipase mainly reflect acute acinar injury and have limited explanatory power for CP fibrosis, acinar atrophy, and decreased exocrine function. CP models should focus on histological staining, α-SMA, Collagen I/III, TGF-β/Smad, hydroxyproline, and ductal reaction indicators.
7.3 Why Does the Alcohol Combined with High-Fat Diet Model Often Need Additional Stimulation?
Alcohol exposure or a high-fat diet alone may sometimes induce only metabolic stress and mild inflammation, and may not reliably form typical CP fibrosis. Combining repeated inflammatory stimulation or other injurious factors can enhance acinar cell injury, stellate cell activation, and collagen deposition, making it more suitable for studying chronic progression of alcoholic or metabolism-related CP.
7.4 How Should Inflammatory Indicators and Histological Results Be Interpreted Together in Pancreatitis Models?
Elevated inflammatory factors indicate that inflammatory responses are activated, but they cannot independently prove the extent of pancreatic tissue injury. In AP models, TNF-α, IL-1β, IL-6, and MPO should be interpreted together with HE score, necrosis extent, and serum enzymology. In CP models, fibrosis staining and ECM indicators should be further combined to determine the degree of chronic remodeling.
7.5 What Is the Significance of TAP Detection in AP Models?
TAP, or trypsinogen activation peptide, reflects the degree of abnormal trypsinogen activation. Compared with serum amylase detection alone, TAP is closer to pancreatic enzyme activation and acinar autodigestion mechanisms, and is suitable for early mechanistic evaluation in AP models such as cerulein, sodium taurocholate, and L-arginine models.
Pancreatitis animal models should be selected according to AP, severe AP, CP fibrosis, or specific etiologies. Chemical models are suitable for acute injury and inflammatory mechanism research. Surgical and dietary models are suitable for chronic progression and fibrosis research. Genetic background models are used to analyze genetic susceptibility and key molecular pathways.
For more related articles, please see below:
[1] The Technology Driving Biomedical Revolution — Animal Modeling
[2] Animal Modeling—Tumor Disease Models
[3] A Detailed Guide to the Construction of Animal Models for Metabolic Diseases
[4] Methods for Establishing Animal Models of Cardiovascular Diseases
[5] Methods for Establishing Models of Nervous System Diseases
[6] Establishment of Common Animal Disease Models and Their Experimental Methods
危险品化学品经营许可证(带存储)